9316 Follow-up study in high-risk uveal melanoma patients

2009 ◽  
Vol 7 (2) ◽  
pp. 582
Author(s):  
P. Mariani ◽  
V. Servois ◽  
S. Piperno-Neumann ◽  
J. Couturier ◽  
C. Plancher ◽  
...  
Keyword(s):  
High Risk ◽  
Uveal Melanoma ◽  
Follow Up Study ◽  
Melanoma Patients

Parental socioeconomic status and prognosis in individuals with ultra-high risk for psychosis: A 2-year follow-up study

2015 ◽  
Vol 168 (1-2) ◽  
pp. 56-61 ◽  
Author(s):  
Ji Won Hur ◽  
Soo-Hee Choi ◽  
Je-Yeon Yun ◽  
Myong-Wuk Chon ◽  
Jun Soo Kwon
Keyword(s):  
Socioeconomic Status ◽  
High Risk ◽  
Follow Up Study ◽  
Ultra High Risk ◽  
Parental Socioeconomic Status

High-risk Age for Rebleeding in Patients with Hemorrhagic Moyamoya Disease: Long-term Follow-up Study

Neurosurgery ◽  
2003 ◽  
Vol 52 (5) ◽  
pp. 1049-1055 ◽  
Author(s):  
Motohiro Morioka ◽  
Jun-ichiro Hamada ◽  
Tatemi Todaka ◽  
Shigetoshi Yano ◽  
Yutaka Kai ◽  
...  
Keyword(s):  
High Risk ◽  
Moyamoya Disease ◽  
Follow Up Study ◽  
Long Term Follow Up

Association of age and viral factors with high-risk HPV persistence: A retrospective follow-up study

2019 ◽  
Vol 154 (2) ◽  
pp. 345-353 ◽  
Author(s):  
Wending Li ◽  
Yifan Meng ◽  
Yi Wang ◽  
Xiaodong Cheng ◽  
Chen Wang ◽  
...  
Keyword(s):  
High Risk ◽  
Follow Up Study ◽  
High Risk Hpv

scholarly journals Emerging tick-borne pathogens in the Nordic countries: A clinical and laboratory follow-up study of high-risk tick-bitten individuals

2020 ◽  
Vol 11 (1) ◽  
pp. 101303
Author(s):  
Lukas Frans Ocias ◽  
Peter Wilhelmsson ◽  
Johanna Sjöwall ◽  
Anna Jonsson Henningsson ◽  
Marika Nordberg ◽  
...  
Keyword(s):  
High Risk ◽  
Nordic Countries ◽  
Follow Up Study

scholarly journals Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling

2020 ◽  
Vol 7 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Amy C Schefler ◽  
Alison Skalet ◽  
Scott C N Oliver ◽  
John Mason ◽  
Anthony B Daniels ◽  
...  
Keyword(s):  
Gene Expression ◽  
Uveal Melanoma ◽  
Clinical Utility ◽  
Medical Oncology ◽  
Treatment Plan ◽  
Risk Class ◽  
Class 1 ◽  
Melanoma Patients ◽  
Metastatic Risk

Aim: The Clinical Application of DecisionDx-UM Gene Expression Assay Results study aimed to evaluate the clinical utility of the prognostic 15-gene expression profile (15-GEP) test for uveal melanoma (UM) patients in a large, prospective multicenter cohort. Patients & methods: Nine centers prospectively enrolled 138 UM patients clinically tested with the 15-GEP. Physician-recommended specialty referrals and metastatic surveillance regimens were collected. Results: A total of 93% of high-risk class 2 patients were referred to medical oncology for follow-up, compared with 51% of class 1 patients. A majority (62%) of class 2 patients were recommended overall high-intensity metastatic surveillance, while 85% of class 1 patients were recommended low-intensity metastatic surveillance. Conclusion: Treatment plan recommendations for UM patients are aligned with GEP-informed metastatic risk, consistent with prior studies.

Sign in / Sign up

Export Citation Format

Share Document